Nalaganje...
Clinical potential of pacritinib in the treatment of myelofibrosis
Myelofibrosis (MF) is a myeloid disorder caused by a clonal hematopoietic stem-cell proliferation associated with activation of the Janus kinase (JAK) signal transducer and activator of transcription (STAT) signaling pathways. Patients with MF often develop severe splenomegaly, marked symptom burden...
Shranjeno v:
| izdano v: | Ther Adv Hematol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publications
2015
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4530369/ https://ncbi.nlm.nih.gov/pubmed/26288713 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620715586527 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|